We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
119 hedge funds and large institutions have $418M invested in Lexicon Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,034% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $1.26M
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
49% more capital invested
Capital invested by funds: $281M → $418M (+$137M)
12% more funds holding
Funds holding: 106 → 119 (+13)
3% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 31
4.86% less ownership
Funds ownership: 75.03% → 70.17% (-4.9%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
119
Holders Change
+13
Holders Change %
+12.26%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
30
Reduced
31
Closed
20
Calls
$14.3M
Puts
$1.26M
Net Calls
+$13M
Net Calls Change
+$13M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$25M |
| 2 |
O
OrbiMed
New York
|
+$7.61M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.02M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.06M |
| 5 |
BlackRock
New York
|
+$1.48M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$48.9M |
| 2 |
JP Morgan Chase
New York
|
-$6.34M |
| 3 |
Morgan Stanley
New York
|
-$3.42M |
| 4 |
Millennium Management
New York
|
-$2.36M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.4M |
